ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1765

Validation of the ACR EULAR Provisional 2017 Classification Criteria of Granulomatosis with Polyangiitis (GPA) Amongst Patients with ANCA Associated Vasculitis

Aman Sharma1, Adarsh MB2, Shankar Naidu3, Manish Rathi4, Benzeeta Pinto5, Varun Dhir6, Roshan Verma7, Kusum Sharma8, Ritambhra Nada9, Sanjay Jain5 and Ranjana Minz10, 1Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India, 2Internal Medicine, PGIMER, Chandigarh, India, 3PGIMER, cHANDIGARH, India, 4Department of Nephrology,, Postgraduate Institute of Medical Education and Research, Chandigarh, India, 5PGIMER, CHANDIGARH, India, 6Internal Medicine (Rheumatology Unit), Postgraduate Institute of Medical Education and Research, Chandigarh, India, 7PGIMER, Chandigarh, India, 8Department of Medical Microbiology,, PGIMER,, Chandigarh, India, 9Histopathology, Professor, Chandigarh, India, 10Department of Immunopathology,, PGIMER,, Chandigarh, India

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: classification criteria and vasculitis, Wegener's granulomatosis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 6, 2017

Title: Vasculitis Poster II: ANCA-Associated Vasculitis

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: The purpose of this study was to validate the recently proposed ACR EULAR 2017 classification criteria of GPA in a real life cohort of ANCA associated vasculitis (AAV).

Methods: The proposed ACR EULAR 2017 criteria of GPA were applied to patients diagnosed to have AAV according to European Medicines Agency (EMA) algorithm. The level of agreement between the two criteria was assessed using CohenÕs kappa, and positive and negative percent agreement (PPA and NPA).

Results: 187 patients with mean age of 41.5±15.0 years were included. Female: male ratio was 1:0.8. ANCA by IIF was done in all patients and was positive in 142(cANCA -97, pANCA -45) . PR3/MPO ELISA was available in 118 patients(PR3-71, MPO- 31). Using EMA algorithm EGPA was diagnosed in 6, GPA in 148 and MPA in 33. With ACR 1990 criteria, GPA was diagnosed in 118 patients while with ACR/EULAR 2017 criteria 115 were classified as GPA. ACR/EULAR 2017 had better agreement with EMA (kappa-0.35, PPA-91.3 and NPA-40.2) than ACR criteria (kappa 0.15, PPA -68.6 and NPA -45.8). The sensitivity and specificity of ACR/EULAR 2017 against EMA GPA was 70.9% and 74.3% respectively. Ten out of thirty three MPA patients were reclassified as GPA by ACR/EULAR 2017 criteria. Out of 43 patients who were GPA by EMA algorithm but not by ACR EULAR 2017 criteria, 37 had lung and renal involvement (DCVAS score 2), three had sinus and renal involvement (DCVAS score 3) and three had lung involvement with MPO positivity (DCVAS score 2). This resulted in low NPA of ACR EULAR 2017 criteria with EMA algorithm.  

Conclusion: Within the limits of a retrospective design, the study showed fair agreement with high PPA but low NPA of ACR/EULAR 2017 criteria with EMA algorithm.

Table 1. Reclassification of various AAV patients (EMA and ACR 1990) by ACR EULAR 2017 provisional criteria of GPA

ANCA associated vasculitis

No. of patients (n=187, %,)

Reclassified as GPA by ACR/EULAR 2017 criteria

ACR 1990 GPA

118(63.1)

79

EMA GPA

148(79.1)

105

EMA MPA

33(17.6)

10

EMA EGPA

6(3.2)

0

Figure 1 – Showing different AAV according to various classification criteria

Description: C:\Users\Dr.Aman\Desktop\Figure 1 ACR abstract GPA final.png

 


Disclosure: A. Sharma, None; A. MB, None; S. Naidu, None; M. Rathi, None; B. Pinto, None; V. Dhir, None; R. Verma, None; K. Sharma, None; R. Nada, None; S. Jain, None; R. Minz, None.

To cite this abstract in AMA style:

Sharma A, MB A, Naidu S, Rathi M, Pinto B, Dhir V, Verma R, Sharma K, Nada R, Jain S, Minz R. Validation of the ACR EULAR Provisional 2017 Classification Criteria of Granulomatosis with Polyangiitis (GPA) Amongst Patients with ANCA Associated Vasculitis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/validation-of-the-acr-eular-provisional-2017-classification-criteria-of-granulomatosis-with-polyangiitis-gpa-amongst-patients-with-anca-associated-vasculitis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/validation-of-the-acr-eular-provisional-2017-classification-criteria-of-granulomatosis-with-polyangiitis-gpa-amongst-patients-with-anca-associated-vasculitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology